Innovation Hallmark 'Barcelona Science Park'
2021 was a key year for the consolidation of PCB community companies’ ability to attract private investment and other sources of funding
2021 was a key year for the consolidation of PCB community companies’ ability to attract private investment and other sources of funding.
Of the total investment raised last year by the startups in the BioRegion of Catalonia, €238 million according to the 2021 Biocat Report, over 16% was attracted by companies located at the Barcelona Science Park, with a joint total of €39 million.
At the top of the list of deals closed by members of the PCB entrepreneurial community is InBrain Neuroelectronics. This deep-tech firm raised €14.3 million, the third-largest round of 2021 in the BioRegion.
Other noteworthy operations by companies at the PCB were carried out by IMIDomics, which closed a $16.5 million (about €14 million) and Nuage Therapeutics, which raised €3.2 million.
“In life sciences, it takes a long time, even years, and money to convert basic research into new products or services that reach society and have an impact on the health of all of us. However, we have many indicators that show how innovative projects are moving towards this destination, how they attract public and private capital, and successfully pass new preclinical and clinical phases and finally reach market. After 20 years of existence, the PCB has created a community of 3,200 professionals that demonstrates the fulfilment of these achievements, from the most basic research to innovation with new products and services”, explains Maria Terrades, CEO of the Barcelona Science Park.
Moreover, the advances in research and development, funding and new science and technical capacities made by the companies that comprise the PCB community reaffirm the Park’s role as a catalyst for innovative activity and the transfer of knowledge and technology to society and consolidate its position as a benchmark ecosystem in Europe.